Butterfly Network [BFLY] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Butterfly Network Inc.

NYSE
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Butterfly Network Inc. wins in 3 metrics, Abbott Laboratories wins in 15 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Butterfly Network Inc. Abbott Laboratories Better
P/E Ratio (TTM) -16.65 25.97 Abbott Laboratories
Price-to-Book Ratio 7.16 3.09 Abbott Laboratories
Debt-to-Equity Ratio 10.41 26.79 Butterfly Network Inc.
PEG Ratio 0.67 -1.41 Butterfly Network Inc.
EV/EBITDA -23.22 13.74 Abbott Laboratories
Profit Margin (TTM) -78.95% 13.90% Abbott Laboratories
Operating Margin (TTM) -36.13% 16.50% Abbott Laboratories
EBITDA Margin (TTM) N/A 16.50% N/A
Return on Equity -42.25% 12.36% Abbott Laboratories
Return on Assets (TTM) -13.17% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $-16.05M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return 89.58% -35.92% Butterfly Network Inc.
Price-to-Sales Ratio (TTM) 14.43 3.57 Abbott Laboratories
Enterprise Value $1.26B $166.96B Abbott Laboratories
EV/Revenue Ratio 12.89 3.70 Abbott Laboratories
Gross Profit Margin (TTM) 67.34% N/A N/A
Revenue per Share (TTM) $0 $26 Abbott Laboratories
Earnings per Share (Diluted) $-0.31 $3.57 Abbott Laboratories
Beta (Stock Volatility) 2.22 0.78 Abbott Laboratories
Short % of Float 12.95% 1.53% Abbott Laboratories

Butterfly Network Inc. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

BFLY
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Butterfly Network Inc.-4.15%-6.20%-9.48%19.29%47.81%17.07%
Abbott Laboratories0.02%1.53%-0.63%-23.43%-30.57%-29.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Butterfly Network Inc.89.58%89.58%-65.69%-55.04%-55.04%-55.04%
Abbott Laboratories-35.92%-17.85%-21.68%118.48%249.25%313.73%

Performance & Financial Health Analysis: Butterfly Network Inc. vs Abbott Laboratories

MetricBFLYABT
Market Information
Market Cap i$1.31B$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,377,69113,495,583
90 Day Avg. Volume i4,491,38712,934,461
Last Close$4.39$86.99
52 Week Range$1.32 - $5.72$81.97 - $139.06
% from 52W High-23.25%-37.44%
All-Time High$29.13 (Feb 15, 2021)$142.60 (Dec 27, 2021)
% from All-Time High-84.93%-39.00%
Growth Metrics
Quarterly Revenue Growth0.41%0.08%
Quarterly Earnings Growth0.41%-0.19%
Financial Health
Profit Margin (TTM) i-0.79%0.14%
Operating Margin (TTM) i-0.36%0.17%
Return on Equity (TTM) i-0.42%0.12%
Debt to Equity (MRQ) i10.4126.79
Cash & Liquidity
Book Value per Share (MRQ)$0.77$30.02
Cash per Share (MRQ)$0.59$5.14
Operating Cash Flow (TTM) i$-12,700,000$10.80B
Levered Free Cash Flow (TTM) i$12.72M$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: Butterfly Network Inc. vs Abbott Laboratories

MetricBFLY (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-16.6525.97
Forward P/E i-55.3015.29
PEG Ratio i0.67-1.41
Price to Sales (TTM) i14.433.57
Price to Book (MRQ) i7.163.09
Market Capitalization
Market Capitalization i$1.31B$160.70B
Enterprise Value i$1.26B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i12.893.70
Enterprise to EBITDA i-23.2213.74
Risk & Other Metrics
Beta i2.220.78
Book Value per Share (MRQ) i$0.77$30.02

Financial Statements Comparison: Butterfly Network Inc. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBFLY (2025)ABT (2025)
Revenue/Sales i97.61M44.33B
Cost of Goods Sold i51.88M19.32B
COGS % of Revenue i53.1%43.6%
Gross Profit i45.73M25.01B
Gross Margin i46.9%56.4%
Research & Development i36.26M2.94B
Operating Income (EBIT) i-86.42M8.05B
Operating Margin i-88.5%18.2%
EBITDA i-69.66M12.03B
EBITDA Margin i-71.4%27.1%
Pre-Tax Income i-76.95M8.47B
Pre-Tax Income % of Revenue i-78.8%19.1%
Income Tax i110,0001.94B
Income Tax % of Revenue i0.1%4.4%
Net Income (Profit) i-77.06M6.52B
Profit Margin i-79.0%14.7%

Balance Sheet & Liquidity Metrics

MetricBFLY (2025)ABT (2025)
Cash & Equivalents i150.49M8.52B
Total Current Assets i249.10M26.00B
Total Current Assets % of Revenue i255.2%58.6%
Total Current Liabilities i65.12M16.50B
Total Current Liabilities % of Revenue i66.7%37.2%
Long-Term Debt i17.72M10.83B
Long-Term Debt % of Revenue i18.2%24.4%
Total Shareholders Equity i195.98M52.77B
Retained Earnings i-879.19M49.78B
Retained Earnings % of Revenue i-900.7%112.3%
Property, Plant & Equipment i12.71M17.57B

Cash Flow Statement Comparison

MetricBFLY (2025)ABT (2025)
Operating Cash Flow i-35.40M10.80B
Operating Cash Flow % of Revenue i-36.3%24.4%
Capital Expenditures i-3.35M-2.17B
Free Cash Flow i-16.05M7.40B
FCF Margin i-16.4%16.7%
Debt Repayment iN/A-1.50B
Common Stock Repurchase iN/A-893.00M

Short Interest & Institutional Ownership Analysis

MetricBFLYABT
Shares Short i25.07M23.83M
Short Ratio i5.361.93
Short % of Float i12.95%1.53%
Shares Outstanding i253.75M1.74B
Float Shares i186.23M1.73B
% Held by Insiders i12.49%0.54%
% Held by Institutions i48.42%82.23%
% Held by Public i39.09%17.23%

Dividend Analysis & Yield Comparison: Butterfly Network Inc. vs Abbott Laboratories

MetricBFLYABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026